Some benzimidazole derivatives were designed and screened via molecular docking. Six compounds which obtained high scores were selected for synthesis and all compounds were characterized by 1 H‐ and 13 C‐ NMR , and HR ‐ ESI ‐ MS . Subsequently, these compounds were evaluated for their inhibitory activities on thrombin. Compound 5a ( IC 50 3.11 n m ) showed a better activity than the reference argatroban ( IC 50 9.88 n m ). These results, along with related molecular model studies, indicated that 5a could be a potential thrombin inhibitor for further research.